Ironwood Pharmaceuticals

About:

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

Website: http://www.ironwoodpharma.com

Twitter/X: ironwoodpharma

Top Investors: F-Prime Capital, Notable Capital, Polaris Partners, Venrock, Morgan Stanley

Description:

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$634M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)ironwoodpharma.com

Founders:

Brian M. Cali, Gina Bornino Miller, Joseph C. Cook, Jr., Peter M. Hecht

Number of Employees:

501-1000

Last Funding Date:

2016-09-26

IPO Status:

Public

© 2025 bioDAO.ai